Treatment strategies of Budd-Chiari syndrome during the epidemic period of 2019 coronavirus disease
10.3760/cma.j.cn112139-20200221-00109
- VernacularTitle: 新型冠状病毒疫情期间巴德-吉亚利综合征患者的治疗策略
- Author:
Luhao LI
1
;
Gong ZHANG
;
Xiaowei DANG
;
Lin LI
Author Information
1. Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Zhengzhou University, Budd-Chiari Syndrome Diagnosis and Treatment Center of Henan Province, Zhengzhou 450052, China
- Publication Type:Journal Article
- Keywords:
Coronavirus infections;
Novel coronavirus pneumonia;
2019 coronavirus disease;
Budd-Chiari syndrome;
Critical cases
- From:
Chinese Journal of Surgery
2020;58(0):E007-E007
- CountryChina
- Language:Chinese
-
Abstract:
Prevention and control about the situation of 2019 coronavirus disease (COVID-19) are grim at present. In addition to supporting the frontline actively, medical workers in general surgery spare no efforts in making good diagnosis and treatment of specialized diseases by optimizing treatment process, providing medical advice online, mastering indications of delayed operation and emergency operation reasonably, etc. Budd-Chiari syndrome is a complex disorder, and severity of the disease varies, serious cases can be life threatening. While fighting the epidemic, medical workers should also ensure the medical needs of patients. However, instead of continuing the traditional treatment, a new management system should be developed. Based on the characteristics of Budd-Chiari syndrome patients in China and our experience, we divide the patients into ordinary and critical cases, and treatment strategies suitable for the epidemic period of COVID-19 are put forward for reference and discussion by physicians.
